Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 21.16
-0.36 (-1.67%)
Aug 24, 2026, 5:31 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 853.74 million as of August 24, 2026. Its market cap has decreased by -17.35% in one year.
Market Cap
853.74M
Enterprise Value
838.99M
Revenue
141.35M
Ranking
n/a
PE Ratio
123.20
Stock Price
21.16
ChartMarket Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 853.74M, a decrease of -73.73%. That is a compound annual growth rate of -11.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 853.74M | -20.65% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 299.69B |
| Novartis AG | 242.19B |
| Lonza Group AG | 41.36B |
| Galderma Group AG | 40.00B |
| SKAN Group AG | 1.47B |
| Idorsia | 1.46B |
| PolyPeptide Group AG | 1.45B |
| Medartis Holding AG | 1.12B |